Aureliano M, C Ohlin A. Decavanadate in vitro and in vivo effects: facts and opinions. J Inorg Biochem. 2014;137:123-30. doi:10.1016/j.jinorgbio.2014.05.002

Aureliano M, Fraqueza G, C Ohlin A. Ion pumps as biological targets for decavanadate. Dalton Trans. 2013;42(33):11770-7. doi:10.1039/c3dt50462j

Fraqueza G, de Carvalho LAEBatist, M Marques PM, et al. Decavanadate, decaniobate, tungstate and molybdate interactions with sarcoplasmic reticulum Ca(2+)-ATPase: quercetin prevents cysteine oxidation by vanadate but does not reverse ATPase inhibition. Dalton Trans. 2012;41(41):12749-58. doi:10.1039/c2dt31688a

Ramos S, Moura JJG, Aureliano M. Recent advances into vanadyl, vanadate and decavanadate interactions with actin. Metallomics. 2012;4(1):16-22. doi:10.1039/c1mt00124h

Fraqueza G, C Ohlin A, Casey WH, Aureliano M. Sarcoplasmic reticulum calcium ATPase interactions with decaniobate, decavanadate, vanadate, tungstate and molybdate. J Inorg Biochem. 2012;107(1):82-9. doi:10.1016/j.jinorgbio.2011.10.010

Tiago DM, Laizé V, Bargelloni L, Ferraresso S, Romualdi C, M. Cancela L. Global analysis of gene expression in mineralizing fish vertebra-derived cell lines: new insights into anti-mineralogenic effect of vanadate. BMC Genomics. 2011;12:310. doi:10.1186/1471-2164-12-310

Ramos S, Almeida RM, Moura JJG, Aureliano M. Implications of oxidovanadium(IV) binding to actin. J Inorg Biochem. 2011;105(6):777-83. doi:10.1016/j.jinorgbio.2011.02.010

Tiago DM, M. Cancela L, Laizé V. Proliferative and mineralogenic effects of insulin, IGF-1, and vanadate in fish osteoblast-like cells. J Bone Miner Metab. 2011;29(3):377-82. doi:10.1007/s00774-010-0243-7

Ramos S, Moura JJG, Aureliano M. Actin as a potential target for decavanadate. J Inorg Biochem. 2010;104(12):1234-9. doi:10.1016/j.jinorgbio.2010.08.001

Ramos S, Duarte RO, Moura JJG, Aureliano M. Decavanadate interactions with actin: cysteine oxidation and vanadyl formation. Dalton Trans. 2009;(38):7985-94. doi:10.1039/b906255f

Aureliano M, Crans DC. Decavanadate (V10 O28 6-) and oxovanadates: oxometalates with many biological activities. J Inorg Biochem. 2009;103(4):536-46. doi:10.1016/j.jinorgbio.2008.11.010

Pereira MJoão, Carvalho E, Eriksson JW, Crans DC, Aureliano M. Effects of decavanadate and insulin enhancing vanadium compounds on glucose uptake in isolated rat adipocytes. J Inorg Biochem. 2009;103(12):1687-92. doi:10.1016/j.jinorgbio.2009.09.015

Laizé V, Tiago DM, Aureliano M, M. Cancela L. New insights into mineralogenic effects of vanadate. Cell Mol Life Sci. 2009;66(24):3831-6. doi:10.1007/s00018-009-0137-9

Tiago DM, Laizé V, M. Cancela L, Aureliano M. Impairment of mineralization by metavanadate and decavanadate solutions in a fish bone-derived cell line. Cell Biol Toxicol. 2008;24(3):253-63. doi:10.1007/s10565-007-9034-x

Aureliano M, Henao F, Tiago T, et al. Sarcoplasmic reticulum calcium ATPase is inhibited by organic vanadium coordination compounds: pyridine-2,6-dicarboxylatodioxovanadium(V), BMOV, and an amavadine analogue. Inorg Chem. 2008;47(13):5677-84. doi:10.1021/ic702405d

Soares SSofia, Henao F, Aureliano M, Gutiérrez-Merino C. Vanadate induces necrotic death in neonatal rat cardiomyocytes through mitochondrial membrane depolarization. Chem Res Toxicol. 2008;21(3):607-18. doi:10.1021/tx700204r

Tiago DM, M. Cancela L, Aureliano M, Laizé V. Vanadate proliferative and anti-mineralogenic effects are mediated by MAPK and PI-3K/Ras/Erk pathways in a fish chondrocyte cell line. FEBS Lett. 2008;582(9):1381-5. doi:10.1016/j.febslet.2008.03.025

Tiago T, Martel P, Gutiérrez-Merino C, Aureliano M. Binding modes of decavanadate to myosin and inhibition of the actomyosin ATPase activity. Biochim Biophys Acta. 2007;1774(4):474-80. doi:10.1016/j.bbapap.2007.02.004

Soares SS, Martins H, Duarte RO, et al. Vanadium distribution, lipid peroxidation and oxidative stress markers upon decavanadate in vivo administration. J Inorg Biochem. 2007;101(1):80-8. doi:10.1016/j.jinorgbio.2006.08.002

Soares SS, Martins H, Aureliano M. Vanadium distribution following decavanadate administration. Arch Environ Contam Toxicol. 2006;50(1):60-4. doi:10.1007/s00244-004-0246-2

Gândara RMC, Soares SS, Martins H, Gutiérrez-Merino C, Aureliano M. Vanadate oligomers: in vivo effects in hepatic vanadium accumulation and stress markers. J Inorg Biochem. 2005;99(5):1238-44. doi:10.1016/j.jinorgbio.2005.02.023